Focus on Alternative and Complementary Therapies
www.pharmpress.com/fact
Focus Alternat Complement Ther©2005 Pharmaceutical Press
Focus Altern Complement Ther 2005; 10: 30
The aim of this study is to present a cumulative five-level model with room for cultural differences for classifying cancer patients’ use of CAM.
CAM level 1: been exposed at least four times to a CAM practitioner in connection with current cancer condition.
CAM level 2: been exposed at least once to a CAM practitioner in connection with current cancer condition.
CAM level 3: includes level 1 and 2 use, and in addition patients who have only used OTC dietary supplements or CAM techniques.
CAM level 4: includes level 1–3 use, and in addition patients who only have used special diets to treat their cancer condition.
CAM level 5: includes level 1–4 use, and in addition patients who used physical activity to treat their current cancer condition.
By applying the model to the responses given by Norwegian cancer patients, we found only 11.1% reporting CAM use at CAM level 1. This proportion increased to 22.7% at CAM level 2, 38.8% at CAM level 3, 40.6% at CAM level 4 and 72.3% at CAM level 5.
The model might serve several purposes since the reader can look for reported CAM use on the level that serves his/her purpose. For researchers the suggested model can be used when utilisation-studies are compared.